Stromal Hedgehog pathway activation by IHH suppresses lung adenocarcinoma growth and metastasis by limiting reactive oxygen species

Autor: Luc Girard, Sahba Kasiri, Ummay Marriam, Barbara Mino, Jashkaran Gadhvi, Katherine Luby-Phelps, Annika Reczek, Baozhi Chen, Evan Noel, Wei Lu, Simbarashe Mazambani, Justin A. Bishop, Luisa M. Solis, Alexandra N. Wilson, Jung Whan Kim, James Kim
Rok vydání: 2019
Předmět:
Cancer microenvironment
0301 basic medicine
Cancer Research
Stromal cell
DNA damage
Adenocarcinoma of Lung
Biology
Ligands
Article
Metastasis
Proto-Oncogene Proteins p21(ras)
Mice
03 medical and health sciences
Paracrine signalling
0302 clinical medicine
Stroma
Genetics
medicine
Animals
Humans
Hedgehog Proteins
Neoplasm Metastasis
Cancer models
Lung
Molecular Biology
Hedgehog
Cell Proliferation
030304 developmental biology
0303 health sciences
Chemistry
medicine.disease
Hedgehog signaling pathway
Acetylcysteine
Antibodies
Anti-Idiotypic

Gene Expression Regulation
Neoplastic

Mechanisms of disease
030104 developmental biology
030220 oncology & carcinogenesis
Mutation
Cancer research
Blood Vessels
Adenocarcinoma
Tumor Suppressor Protein p53
Signal transduction
Reactive Oxygen Species
Non-small-cell lung cancer
Tumour angiogenesis
DNA Damage
Signal Transduction
Zdroj: Oncogene
DOI: 10.1101/747915
Popis: Activation of the Hedgehog (Hh) signaling pathway by mutations within its components drives the growth of several cancers. However, the role of Hh pathway activation in lung cancers has been controversial. Here, we demonstrate that the canonical Hh signaling pathway is activated in lung stroma by Hh ligands secreted from transformed lung epithelia. Genetic deletion ofShh, the primary Hh ligand expressed in the lung, inKrasG12D/+;Trp53fl/flautochthonous murine lung adenocarcinoma had no effect on survival. Early abrogation of the pathway by an anti-SHH/IHH antibody 5E1 led to significantly worse survival with increased tumor and metastatic burden. Loss of IHH, another Hh ligand, by in vivo CRISPR led to more aggressive tumor growth suggesting that IHH, rather than SHH, activates the pathway in stroma to drive its tumor suppressive effects—a novel role for IHH in the lung. Tumors from mice treated with 5E1 had decreased blood vessel density and increased DNA damage suggestive of reactive oxygen species (ROS) activity. Treatment ofKrasG12D/+;Trp53fl/flmice with 5E1 and N-acetylcysteine, as a ROS scavenger, decreased tumor DNA damage, inhibited tumor growth and prolonged mouse survival. Thus, IHH induces stromal activation of the canonical Hh signaling pathway to suppress tumor growth and metastases, in part, by limiting ROS activity.
Databáze: OpenAIRE